Next earnings date: 22 Oct 2025
Strides Pharma Science Limited – NSE:STAR.NS
Strides Pharma Science Limited stock price today
Strides Pharma Science Limited stock price monthly change
Strides Pharma Science Limited stock price quarterly change
Strides Pharma Science Limited stock price yearly change
Strides Pharma Science Limited key metrics
Market Cap | 64.44B |
Enterprise value | 84.39B |
P/E | 27.00 |
EV/Sales | 1.91 |
EV/EBITDA | 9.65 |
Price/Sales | 1.41 |
Price/Book | 2.75 |
PEG ratio | 2.72 |
EPS | -13.84 |
Revenue | 40.51B |
EBITDA | 6.75B |
Income | -706.14M |
Revenue Q/Q | 9.90% |
Revenue Y/Y | 9.83% |
Profit margin | 5.24% |
Oper. margin | 14.54% |
Gross margin | 42.51% |
EBIT margin | 14.54% |
EBITDA margin | 16.69% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeStrides Pharma Science Limited stock price history
Strides Pharma Science Limited stock forecast
Strides Pharma Science Limited financial statements
| Jun 2023 | 9.29B | -71.13M | -0.76% |
|---|---|---|---|
| Sep 2023 | 9.99B | -1.31B | -13.14% |
| Dec 2023 | 10.37B | 496.67M | 4.79% |
| Mar 2024 | 10.84B | 181.75M | 1.68% |
| 2026 | 50.75B | 4.44B | 8.76% |
|---|
Analysts Price target
Financials & Ratios estimates
| Payout ratio | 0% |
|---|
| 2016 | 0.27% |
|---|---|
| 2017 | 0.39% |
| 2019 | 0.42% |
| 2020 | 5.33% |
| 2022 | 0.72% |
| Jun 2023 | 0 | 0 | |
|---|---|---|---|
| Sep 2023 | 63378040000 | 43.44B | 68.55% |
| Dec 2023 | 0 | 0 | |
| Mar 2024 | 58397550000 | 37.68B | 64.52% |
| Jun 2023 | 1.19B | 0 | 0 |
|---|---|---|---|
| Sep 2023 | 1.20B | 0 | 0 |
| Dec 2023 | 1.02B | 0 | 0 |
| Mar 2024 | 0 | 0 | 0 |
Strides Pharma Science Limited alternative data
| Aug 2023 | 2,647 |
|---|---|
| Sep 2023 | 2,850 |
| Oct 2023 | 2,850 |
| Nov 2023 | 2,850 |
| Dec 2023 | 2,850 |
| Jan 2024 | 2,850 |
| Feb 2024 | 2,850 |
| Mar 2024 | 2,850 |
| Apr 2024 | 2,850 |
| May 2024 | 2,850 |
| Jun 2024 | 2,850 |
| Jul 2024 | 2,850 |
Strides Pharma Science Limited other data
| Insider | Compensation |
|---|---|
Dr. R. Ananthanarayanan B.Pharm., Ph.D. (1965) Chief Executive Officer, MD & Director | $118,050,000 |
Mr. Badree Komandur (1972) Group Chief Financial Officer, Executive Director of Fin. & Executive Director | $43,760,000 |
-
What's the price of Strides Pharma Science Limited stock today?
One share of Strides Pharma Science Limited stock can currently be purchased for approximately $456.25.
-
When is Strides Pharma Science Limited's next earnings date?
Strides Pharma Science Limited is estimated to report earnings on Wednesday, 22 Oct 2025.
-
Does Strides Pharma Science Limited pay dividends?
Yes, Strides Pharma Science Limited pays dividends and its trailing 12-month yield is 0.37% with 0% payout ratio. The last Strides Pharma Science Limited stock dividend of $0 was paid on 4 Sep 2025.
-
How much money does Strides Pharma Science Limited make?
Strides Pharma Science Limited has a market capitalization of 64.44B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 28.75% to 38.91B US dollars.
-
What is Strides Pharma Science Limited's stock symbol?
Strides Pharma Science Limited is traded on the NSE under the ticker symbol "STAR.NS".
-
What is Strides Pharma Science Limited's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Strides Pharma Science Limited?
Shares of Strides Pharma Science Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Strides Pharma Science Limited's key executives?
Strides Pharma Science Limited's management team includes the following people:
- Dr. R. Ananthanarayanan B.Pharm., Ph.D. Chief Executive Officer, MD & Director(age: 60, pay: $118,050,000)
- Mr. Badree Komandur Group Chief Financial Officer, Executive Director of Fin. & Executive Director(age: 53, pay: $43,760,000)
-
How many employees does Strides Pharma Science Limited have?
As Jul 2024, Strides Pharma Science Limited employs 2,850 workers.
-
When Strides Pharma Science Limited went public?
Strides Pharma Science Limited is publicly traded company for more then 23 years since IPO on 26 Jun 2002.
-
What is Strides Pharma Science Limited's official website?
The official website for Strides Pharma Science Limited is strides.com.
-
How can i contact Strides Pharma Science Limited?
Strides Pharma Science Limited can be reached via phone at +91 80678 40000.
Strides Pharma Science Limited company profile:
Strides Pharma Science Limited
strides.comNSE
3,065
Drug Manufacturers - Specialty & Generic
Healthcare
Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, powders, solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.
Bengaluru, 560076
:
ISIN: INE939A01011
CUSIP: Y8175G117
